Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v8-FR Version v7-EN
Language French English
Date Updated 2023-05-16 2023-05-16
Drug Identification Number 02247600 02247600
Brand name BOOSTRIX BOOSTRIX
Common or Proper name Combined diphtheria, tetanus, acellular pertussis (adsorbed) vaccine for booster vaccination Combined diphtheria, tetanus, acellular pertussis (adsorbed) vaccine for booster vaccination
Company Name GLAXOSMITHKLINE INC GLAXOSMITHKLINE INC
Ingredients PERTACTIN FILAMENTOUS HAEMAGGLUTININ PERTUSSIS TOXOID TETANUS TOXOID DIPHTHERIA TOXOID PERTACTIN FILAMENTOUS HAEMAGGLUTININ PERTUSSIS TOXOID TETANUS TOXOID DIPHTHERIA TOXOID
Strength(s) 2.5MCG 8MCG 8MCG 20UNIT 2UNIT 2.5MCG 8MCG 8MCG 20UNIT 2UNIT
Dosage form(s) SUSPENSION SUSPENSION
Route of administration INTRAMUSCULAR INTRAMUSCULAR INTRAMUSCULAR INTRAMUSCULAR
Packaging size 10s 10s
ATC code J07AX J07AX
ATC description BACTERIAL VACCINES BACTERIAL VACCINES
Reason for shortage Delay in shipping of the drug. Delay in shipping of the drug.
Anticipated start date
Actual start date 2023-01-03 2023-01-03
Estimated end date 2023-05-16 2023-05-16
Actual end date 2023-05-15 2023-05-15
Shortage status Resolved Resolved
Tier 3 Status No No
Company comments Supply unavailable Supply unavailable
Health Canada comments